Company Valuation: SMS Pharmaceuticals Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2021 2022 2023 2024 2025 2026
Market Cap 1 10,518 7,915 4,931 15,089 18,863 35,105
Change - -24.75% -37.7% 206.01% 25.01% 86.1%
Enterprise Value (EV) 1 12,660 10,082 7,398 17,536 21,556 38,296
Change - -20.36% -26.62% 137.04% 22.93% 77.66%
P/E 16.8x 12.7x -69.9x 30.3x 27.3x 33.6x
PBR 2.56x 1.68x 1.07x 2.81x 2.95x 4.47x
PEG - -25.87x 1x -0x 0.8x 0.8x
Capitalization / Revenue 1.86x 1.52x 0.94x 2.13x 2.41x 3.95x
EV / Revenue 2.24x 1.94x 1.42x 2.47x 2.75x 4.31x
EV / EBITDA 10.3x 8.83x 13.7x 15x 15.5x 22.1x
EV / EBIT 12.5x 12.1x 32.5x 20.4x 20.5x 28.6x
EV / FCF -12.4x -44.8x -23.4x -70.3x -31x -41.1x
FCF Yield -8.04% -2.23% -4.27% -1.42% -3.22% -2.43%
Dividend per Share 2 0.3 0.3 0.3 0.4 0.4 0.4
Rate of return 0.24% 0.32% 0.52% 0.22% 0.19% 0.11%
EPS 2 7.386 7.35 -0.8339 5.886 7.799 11.15
Distribution rate 4.06% 4.08% -36% 6.8% 5.13% 3.59%
Net sales 1 5,651 5,199 5,221 7,093 7,827 8,886
EBITDA 1 1,227 1,142 541.8 1,169 1,387 1,735
EBIT 1 1,014 830.7 227.3 860.1 1,049 1,338
Net income 1 625.3 622.2 -70.59 498.3 691.4 1,020
Net Debt 1 2,142 2,167 2,467 2,447 2,693 3,191
Reference price 2 124.25 93.50 58.25 178.25 212.78 374.85
Nbr of stocks (in thousands) 84,652 84,652 84,652 84,652 88,652 93,652
Announcement Date 9/8/21 9/7/22 9/7/23 9/6/24 9/6/25 9/4/26
1INR in Million2INR
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 409M
37.06x13.1x27.8x0.54% 1,135B
38.61x6.49x18.27x2.02% 635B
36.46x8.38x17.33x2.41% 505B
20.87x5.11x12.73x2.56% 378B
105.89x5.92x25.41x2.34% 358B
21.76x5.68x13.94x2.81% 295B
22.43x4.53x12.94x1.95% 266B
27.87x7.16x12.81x2.3% 237B
-45.48x6.98x27.06x2.11% 193B
Average 29.50x 7.04x 18.70x 2.12% 400.41B
Weighted average by Cap. 35.23x 8.29x 20.40x 1.8%

Y-o-Y evolution of P/E

Valuation ratios - P/E - SMS Pharmaceuticals Limited

Historical PBR trend

Valuation ratios - PBR - SMS Pharmaceuticals Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - SMS Pharmaceuticals Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - SMS Pharmaceuticals Limited

  1. Stock Market
  2. Stocks
  3. SMSPHARMA Stock
  4. Valuation SMS Pharmaceuticals Limited